BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33346151)

  • 1. Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.
    Fuchs D; Kilbertus A; Kofler K; von Bubnoff N; Shoumariyeh K; Zanotti R; Bonadonna P; Scaffidi L; Doubek M; Elberink HO; Span LFR; Hermine O; Elena C; Benvenuti P; Yavuz AS; Brockow K; Zink A; Aberer E; Gorska A; Romantowski J; Hadzijusufovic E; Fortina AB; Caroppo F; Perkins C; Illerhaus A; Panse J; Vucinic V; Jawhar M; Sabato V; Triggiani M; Parente R; Bergström A; Breynaert C; Gotlib J; Reiter A; Hartmann K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Sperr WR; Greul R; Valent P
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1705-1712.e4. PubMed ID: 33346151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
    Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
    J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study.
    Fradet M; Negretto M; Tournier E; Laurent C; Apoil PA; Evrard S; Degboe Y; Del Mas V; Lamant L; Dubreuil P; Laroche M; Mailhol C; Hermine O; Paul C; Bulai Livideanu C
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1713-1718. PubMed ID: 31009132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
    Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
    Leukemia; 2022 Feb; 36(2):516-524. PubMed ID: 34545185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
    Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
    Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
    [No Abstract]   [Full Text] [Related]  

  • 8. The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
    Merante S; Ferretti VV; Elena C; Brazzelli V; Zanotti R; Neri I; Magliacane D; Belloni Fortina A; Ingeborg F; Pastorello EA; Pieri L; Papayannidis C; Mauro M; Grifoni F; Minelli R; Guggiari E; Difonzo E; Bocchia M; Caroppo F; Di Nuzzo S; Elli EM; Rondoni M; Ciccocioppo R; Di Stefano M; Bossi G; Boveri E; Bonadonna P; Giona F; Valent P; Triggiani M
    Future Oncol; 2018 Nov; 14(26):2713-2723. PubMed ID: 30207489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis: a comprehensive insight.
    VAN Gysel D; DE Maeseneer H; Oranje AP
    G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of paediatric mastocytosis: a review of 101 cases.
    Lange M; Niedoszytko M; Renke J; Gleń J; Nedoszytko B
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):97-102. PubMed ID: 22126331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
    Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
    Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
    Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
    Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for fragility fracture in systemic mastocytosis.
    Degboé Y; Eischen M; Nigon D; Apoil PA; Mailhol C; Tournier E; Laurent C; Hanssens K; Hermine O; Paul C; Laroche M; Bulai-Livideanu C
    Bone; 2017 Dec; 105():219-225. PubMed ID: 28919366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastocytosis in children: a single-center long-term follow-up study.
    Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
    Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis.
    Gülen T; Ljung C; Nilsson G; Akin C
    J Allergy Clin Immunol Pract; 2017; 5(5):1248-1255. PubMed ID: 28351784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic mastocytosis].
    Niedoszytko M; Lange M; Chelminska M; Jaśkiewicz K; Piskosz A; Wasag B; Lewandowski K; Mital A; Renke J; Gruchała-Niedoszytko M; Woźniak M; Babińska A; Jassem E
    Pneumonol Alergol Pol; 2005; 73(3):239-44. PubMed ID: 16989160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
    Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
    Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.